CD30-positive lymphoproliferative disorders arising after regional therapy for recurrent melanoma: A report of two cases and analysis of CD30 expression Academic Article uri icon

Overview

MeSH Major

  • Antigens, CD30
  • Lymphocytes
  • Lymphoma, Large-Cell, Anaplastic
  • Lymphomatoid Papulosis
  • Neoplasms, Second Primary
  • Skin Neoplasms

abstract

  • We hypothesize that ILP/ILI causes upregulation of CD30 expression in the extremities of treated patients, and suggest that this may be a marker of treatment response. However, a rare but long-term effect may be an increased risk of T-cell cutaneous lymphoproliferative disease in the affected limb.

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/jso.23636

PubMed ID

  • 24891295

Additional Document Info

start page

  • 258

end page

  • 64

volume

  • 110

number

  • 3